JP2008512401A - 直腸又は膣投与のための薬学的組成物、それらを製造する方法及びそれらの薬剤としての使用 - Google Patents

直腸又は膣投与のための薬学的組成物、それらを製造する方法及びそれらの薬剤としての使用 Download PDF

Info

Publication number
JP2008512401A
JP2008512401A JP2007530575A JP2007530575A JP2008512401A JP 2008512401 A JP2008512401 A JP 2008512401A JP 2007530575 A JP2007530575 A JP 2007530575A JP 2007530575 A JP2007530575 A JP 2007530575A JP 2008512401 A JP2008512401 A JP 2008512401A
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
group
active substance
rectal
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007530575A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008512401A5 (https=
Inventor
フランツ，アレシ
ソヴァ，ペトル
Original Assignee
プリヴァ−ラケマ，エー．エス．
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by プリヴァ−ラケマ，エー．エス． filed Critical プリヴァ−ラケマ，エー．エス．
Publication of JP2008512401A publication Critical patent/JP2008512401A/ja
Publication of JP2008512401A5 publication Critical patent/JP2008512401A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2007530575A 2004-09-08 2005-09-07 直腸又は膣投与のための薬学的組成物、それらを製造する方法及びそれらの薬剤としての使用 Pending JP2008512401A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ20040945A CZ296169B6 (cs) 2004-09-08 2004-09-08 Farmaceutická kompozice pro rektální nebo vaginální podání, zpusob její prípravy a tato kompozice pro pouzití jako lécivo
PCT/CZ2005/000068 WO2006026935A2 (en) 2004-09-08 2005-09-07 Pharmaceutical composition for rectal or vaginal application comprising a platinum complex

Publications (2)

Publication Number Publication Date
JP2008512401A true JP2008512401A (ja) 2008-04-24
JP2008512401A5 JP2008512401A5 (https=) 2008-08-21

Family

ID=35429577

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007530575A Pending JP2008512401A (ja) 2004-09-08 2005-09-07 直腸又は膣投与のための薬学的組成物、それらを製造する方法及びそれらの薬剤としての使用

Country Status (7)

Country Link
US (1) US20080008740A1 (https=)
EP (1) EP1809274B1 (https=)
JP (1) JP2008512401A (https=)
AT (1) ATE465727T1 (https=)
CZ (1) CZ296169B6 (https=)
DE (1) DE602005020964D1 (https=)
WO (1) WO2006026935A2 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017532305A (ja) * 2014-09-03 2017-11-02 ブイユーエービー ファーマ エー．エス． 増加した抗腫瘍効果を有する白金（ｉｖ）錯体

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ2004964A3 (cs) * 2004-09-14 2006-03-15 Pliva-Lachema A. S. Perorální farmaceutická kompozice pro cílený transport komplexu platiny do kolorektální oblasti, zpusob její prípravy a tato kompozice pro pouzití jako lécivo
CZ300590B6 (cs) * 2006-06-20 2009-06-24 Pliva - Lachema A. S. Farmaceutická kompozice pro injekcní podání
US8217083B2 (en) * 2007-06-08 2012-07-10 Aptalis Pharma Canada Inc. Mesalamine suppository
US8436051B2 (en) * 2007-06-08 2013-05-07 Aptalis Pharma Canada Inc. Mesalamine suppository
US7541384B2 (en) 2007-06-08 2009-06-02 Axcan Pharma Inc. Mesalamine suppository
PT3386997T (pt) 2015-12-09 2021-11-04 Univ Wien Med Compostos de platina com funções de mono-maleimida para a terapêutica do cancro
WO2022211646A1 (en) * 2021-03-30 2022-10-06 Master Pharm S.A. Globule comprising cetraria islandica thallus extract and the method of its preparation
IL310790A (en) * 2021-08-19 2024-04-01 Jabil Inc A method for creating polyprolactone powder by repeated precipitation and its subsequent use in additive manufacturing

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5446826A (en) * 1977-08-24 1979-04-13 Yamanouchi Pharmaceut Co Ltd Slow-release rectal suppository
JPS63303923A (ja) * 1987-05-14 1988-12-12 ファンダテック　エス．アー． 避妊座薬およびその製造方法
JPH10265380A (ja) * 1997-03-17 1998-10-06 Bristol Myers Squibb Co 抗ガン剤
JP2002516332A (ja) * 1998-05-27 2002-06-04 プリヴァ−ラケマ，エー．エス． 白金錯体、その製造方法および治療学的適用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4786725A (en) * 1982-06-28 1988-11-22 Engelhard Corporation Solubilized platinum (II) complexes
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
US5192802A (en) * 1991-09-25 1993-03-09 Mcneil-Ppc, Inc. Bioadhesive pharmaceutical carrier
ATE347367T1 (de) * 2003-10-13 2006-12-15 Zoser B Salama Pharmazeutische zusammensetzung umfassend oxoplatin und dessen salze

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5446826A (en) * 1977-08-24 1979-04-13 Yamanouchi Pharmaceut Co Ltd Slow-release rectal suppository
JPS63303923A (ja) * 1987-05-14 1988-12-12 ファンダテック　エス．アー． 避妊座薬およびその製造方法
JPH10265380A (ja) * 1997-03-17 1998-10-06 Bristol Myers Squibb Co 抗ガン剤
JP2002516332A (ja) * 1998-05-27 2002-06-04 プリヴァ−ラケマ，エー．エス． 白金錯体、その製造方法および治療学的適用

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017532305A (ja) * 2014-09-03 2017-11-02 ブイユーエービー ファーマ エー．エス． 増加した抗腫瘍効果を有する白金（ｉｖ）錯体

Also Published As

Publication number Publication date
DE602005020964D1 (de) 2010-06-10
WO2006026935A3 (en) 2006-10-05
CZ2004945A3 (cs) 2006-01-11
CZ296169B6 (cs) 2006-01-11
ATE465727T1 (de) 2010-05-15
US20080008740A1 (en) 2008-01-10
EP1809274A2 (en) 2007-07-25
EP1809274B1 (en) 2010-04-28
WO2006026935A2 (en) 2006-03-16

Similar Documents

Publication Publication Date Title
CN1196477C (zh) 用于口服给药的药物组合物
JP2010510983A (ja) 前立腺関連疾患の治療および予防のための化合物およびそれを含有する結腸送達系の医薬組成物
KR20090113852A (ko) 암 치료용 제제
JP2002514227A (ja) パロキセチン固体分散体の新規な製造方法
EA026213B1 (ru) Термостабильная твердая фармацевтическая композиция, содержащая наномицеллы, и способ ее получения
JP2008512401A (ja) 直腸又は膣投与のための薬学的組成物、それらを製造する方法及びそれらの薬剤としての使用
EA027641B1 (ru) Продукт сомикронизации, включающий ацетат улипристала
TW202045185A (zh) 用於治療過度增生疾病之atr激酶抑制劑
CN105456200B (zh) 一种提高难溶性药物口服生物利用度的纳米粒微球的制备方法及应用
ES2407408T3 (es) Sistemas terapéuticos de liberación inmediata para mejorar la absorción oral de 7-[(E)-terc-butiloxiiminometil]camptotecina
JP2008512401A5 (https=)
JP2013530930A (ja) 放射線増感剤組成物
JP5256739B2 (ja) ビンカアルカロイド誘導体の安定固体分散体とその製造方法
WO2019208617A1 (ja) ソラフェニブの経口デリバリー用組成物及びその使用
CN101492452B (zh) 含有二氧杂环庚烷并吡啶的巯基苯并咪唑衍生物
CN101497605B (zh) 含有被烷氧基取代的吡啶的苯并咪唑衍生物
KR100679925B1 (ko) 신규한 ５―플루오로우라실 좌제 조성물
CN101744803A (zh) 冬凌草甲素固体分散体的制备方法
EP0487768A1 (en) Pharmaceutical composition with improved dissolution property
CN118512446A (zh) 3,5-二取代-7氮杂吲哚衍生物在制备治疗结肠炎药物中的应用
CN101497603B (zh) 含有被烷氧烷胺氧基取代的吡啶的苯并咪唑衍生物
WO2024180209A1 (en) Crystalline form of midazolam hydrochloride
RU2696870C2 (ru) Пероральный препарат с замедленным высвобождением
CN116407554A (zh) 降低靶向抗肿瘤药物对肠道损伤的药物及其应用
CN101497622B (zh) 吡啶甲基亚磺酰基咪唑并吡啶衍生物

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080704

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080704

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110801

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20111101

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20111109

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20120509